Please login to the form below

Not currently logged in


This page shows the latest VIR-7831 news and features for those working in and with pharma, biotech and healthcare.

GSK, Vir’s COVID-19 mAb scores FDA emergency use approval

GSK, Vir’s COVID-19 mAb scores FDA emergency use approval

The EUA clears sotrovimab – previously known as VIR-7831 – for the treatment of mild-to-moderate COVID-19 in high-risk adults and certain paediatric patients who have a positive ... In addition to the positive phase 3 results, GSK and Vir said

Latest news

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....